期刊文献+

骨髓衰竭的端粒效应

原文传递
导出
摘要 再生障碍性贫血(AA)为骨髓造血功能衰竭所致全血细胞减少的一组异质性疾病。尽管细胞免疫异常已被公认为AA发病机制中的主要环节,然仍有部分AA患者免疫抑制治疗无效。此类患者较之免疫抑制治疗有效者及同年龄正常人,其染色体端粒长度明显缩短且端粒酶活性亦存异常。笔者就AA患者端粒及其相关组成异常变化的病理生理机制进行综述。
出处 《国际输血及血液学杂志》 CAS 2012年第5期450-453,共4页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献24

  • 1Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood, 2012,119(10) :2963-2965.
  • 2Gadalla SM, Savage SA. Telomere biology in hematopoiesis and stem cell transDlantation. Blood Revo 2011,25(6):261-269.
  • 3Young NS. Telomere biology and telomere diseases: implications for practice and research. Hematology Am Soc Hematol Educ Program, 2010,30-35.
  • 4Aalbers AM, Kajigaya S, van den Heuvel-Eibrink MM, et al. Human telomere disease due to disruption of the CCAAT box of the TERC promoter. Blood, 2012,119(13):3060-3063.
  • 5Ziegler P, Schrezenrneier H, Akkad J, et al. Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Ann Hematol. 2012,91(7):1115 -1120.
  • 6de Lange T. How 1elomeres solve the end protection problem. Science, 2009, 326(5955);948 -952.
  • 7Gadalla SM, Cawthon R, Giri N, et al. Telomere length in blood, buccal ceils, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY), 2010, 2 (11) :867-874.
  • 8Vulliamy T, Marrone A, Dokal I, et al. Association between aplastic anemia and mutations in telomerase RNA. Lancet, 2002, 359(9324) :2168-2170.
  • 9Calado RT, Cooper JN, Padilla-Nash HM, et al. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia, 2012, 26(4):700- 707.
  • 10Fogarty PF,Yamaguchi H,Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastie anemia due to mutations in telomerase RNA. Lancet, 2003, 362(9396) 1628-1630.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部